← FDA Drug Approvals (Drugs@FDA)

CARBIDOPA AND LEVODOPA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-09-21

Drug application

FDA Application #

ANDA216505

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARBIDOPA AND LEVODOPA

Generic name

CARBIDOPA AND LEVODOPA

Active ingredients

CARBIDOPA; LEVODOPA

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Advagen Pharma Ltd.,

First approval

2022-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown